Trial intelligence / Profile preview

High-dose atorvastatin in post-coarctectomy patients

NL-OMON31321Phase 3Not yet recruiting

Sponsor
Amsterdam University Medical Center
Start
Sep 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, open-label trial of atorvastatin in Coarctation of the aorta (CoA) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: Change in carotid intima-media thickness. Planned start Sep 2007; status: not yet recruiting.

02

Drugs

atorvastatin
03

Conditions

Coarctation of the aorta (CoA)

Beyond the preview

Go deeper on NL-OMON31321.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON31321.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call